SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-019430
Filing Date
2019-05-15
Accepted
2019-05-15 16:30:25
Documents
6
Period of Report
2019-07-11
Effectiveness Date
2019-05-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A nvus-def14a_20190711.htm DEF 14A 795314
2 GRAPHIC gm30tr1z1qg5000004.jpg GRAPHIC 70393
3 GRAPHIC gm30tr1z1qg5000003.jpg GRAPHIC 4022
4 GRAPHIC gm30tr1z1qg5000002.jpg GRAPHIC 2177
5 GRAPHIC gm30tr1z1qg5000005.jpg GRAPHIC 53926
6 GRAPHIC gm30tr1z1qg5000001.jpg GRAPHIC 4022
  Complete submission text file 0001564590-19-019430.txt   982518
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36620 | Film No.: 19828719
SIC: 2834 Pharmaceutical Preparations